Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
| Errataetall: |
CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102170. - PMID 34653614 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:325 |
|---|---|
| Enthalten in: |
JAMA - 325(2021), 14 vom: 13. Apr., Seite 1467-1469 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Saadat, Saman [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Neutralizing |
|---|
| Anmerkungen: |
Date Completed 19.04.2021 Date Revised 13.12.2023 published: Print CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102170. - PMID 34653614 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jama.2021.3341 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322039606 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322039606 | ||
| 003 | DE-627 | ||
| 005 | 20231227130443.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2021.3341 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1224.xml |
| 035 | |a (DE-627)NLM322039606 | ||
| 035 | |a (NLM)33646292 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Saadat, Saman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.04.2021 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Travel Med Infect Dis. 2021 Nov-Dec;44:102170. - PMID 34653614 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Vaccines, Synthetic |2 NLM | |
| 700 | 1 | |a Rikhtegaran Tehrani, Zahra |e verfasserin |4 aut | |
| 700 | 1 | |a Logue, James |e verfasserin |4 aut | |
| 700 | 1 | |a Newman, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Frieman, Matthew B |e verfasserin |4 aut | |
| 700 | 1 | |a Harris, Anthony D |e verfasserin |4 aut | |
| 700 | 1 | |a Sajadi, Mohammad M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 325(2021), 14 vom: 13. Apr., Seite 1467-1469 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
| 773 | 1 | 8 | |g volume:325 |g year:2021 |g number:14 |g day:13 |g month:04 |g pages:1467-1469 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2021.3341 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 325 |j 2021 |e 14 |b 13 |c 04 |h 1467-1469 | ||